Clinical relevance of cognitive scores in hepatitis C patients with advanced fibrosis

Journal of Clinical and Experimental Neuropsychology

Volumn 28, Issue 8, 2006, Pages 1346-1361

  Bieliauskas, Linas A ^a,b   Back Madruga, Carla ^c   Lindsay, Karen L ^c   Snow, Kristin K ^d   Kronfol, Ziad ^a   Lok, Anna S ^a   Padmanabhan, Latha ^d   Fontana, Robert J ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d NEW ENGLAND RESEARCH INSTITUTES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL EXAMINATION; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; FUNCTIONAL STATUS; GLOBAL DEFICIT SCORE; HEPATITIS C; HUMAN; KAPPA STATISTICS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SELF REPORT; SHORT FORM 36; STANDARD;

ADULT; COGNITION; COGNITION DISORDERS; DEMOGRAPHY; FEMALE; FIBROSIS; HEPATITIS C; HUMANS; INTELLIGENCE TESTS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; ROC CURVE; SEVERITY OF ILLNESS INDEX; STATISTICS;

EID: 33750127972     PISSN: 13803395     EISSN: 1744411X     Source Type: Journal    
DOI: 10.1080/13803390500473720     Document Type: Article

References (41)

1. Back-Madruga, C., Fontana, R., Bieliauskas, L.A., Burton-Williams, M., Wright, E., Padmanabhan, L., Sleeper, H., Kronfol, Z., Lindsay, K., & The HALT-C Trial Study Group. (2003). Predictors of cognitive impairment in chronic hepatitis C patients entering the HALT-C trial (Abstract). Journal of the International Neuropsychological Society, 9, 245.
2. Beck, A.T., Steer, R.A., & Brown, G.K. (eds.) (1996). Manual for the Beck Depression Inventory-II. San Antonio, TX: The Psychological Corporation.
3. Benton, A.L., Sivan, A.B., Hamsher, K. deS., Varney, N.R., & Spreen, O. (1994). Contributions to neuropsychological assessment. New York, NY: Oxford University Press.
4. Berger, J.R., & Arendt, G. (2000). HIV dementia: The role of the basal ganglia and dopaminergic systems. Journal of Psychopharmacology, 14, 214-221.
5. Berger, J.R., Greenberg, N.A., Andersen, A.H., Greene, R.A., Bognar, A., & Avison, M.J. (2000). Cerebrovascular changes in the basal ganglia with HIV dementia. Neurology, 54, 921-926.
6. Bieliauskas, L.A. (1996). Practical approaches to ecological validity of neuropsychological measures in the elderly. In R.J. Sbordone & C.J. Long (eds.), Ecological validity of neuropsychological testing (pp. 261-282). Delray Beach, GL: GR Press/St. Lucie Press.
7. Bonkovsky, H.L., Woolley, J.M. & the Consensus Interferon Study Group (1999). Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. Journal of Hepatology, 29, 264-270.
8. Butters, N., Grant, I., Haxby, J., Judd L.L., Martin, A., & McClelland, J. (1990). Assessment of AIDS-related cognitive changes: Recommendations of the NIMH Workshop on Neuropsychological Assessment Approaches. Journal of Clinical and Experimental Neuropsychology, 12, 963-978.
9. Carey, C.L., Woods, S.P., Gonzalez, R., Conover, E., Marcotte, T.D., & Grant, I. (2004). Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. Journal of Clinical and Experimental Neuropsychology, 26, 307-319.
10. Derogatis, L.R. & Melisaratos, N. (1983). The Brief Symptom Inventory: An introductory report. Psychosomatic Medicine, 13, 595-605, 1983.
11. Fontana, R.J., Bieliauskas, L.A., Back-Madruga, C., Lindsay, K.L., Kronfol, Z., & Lok, A.S. (in press). Cognitive function in Hepatitis C patients with advanced fibrosis: Results from the HALT-C trial. Journal of Hepatology.
12. Fontana, R.J., Hussain, K.V., Schwartz, S.M., Moyer, C.A., Su, G.L., & Lok, A.S. (2002). Emotional distress in chronic hepatitis C patients not receiving antiviral therapy. Journal of Hepatology, 36, 435-438.
13. Forton, D.M., Allsop, J.M., Main, J., Foster, G.R., Thomas, H.D., & Taylor-Robinson, S.D. (2001). Evidence for a cerebral effect of the hepatitis C virus. Lancet, 358, 38-39.
14. Forton, D.M., Taylor-Robinson, S.D., & Thomas, H.C. (2002). Reduced quality of life in hepatitis C-is it all in the head? Journal of Hepatology, 36, 435-438.
15. Forton, D.M., Thomas, H.C., Murphy, C.A., Allsop, J.M., Foster, G.R., Main, J., Wesnes, K.A., & Taylor-Robinson, S.D. (2002). Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology, 35, 433-439.
16. Gescheider, G.A. (1976). Psychophysics: Method and theory. Hillsdale, NJ: L.A. Erlbaum Associates.
17. Hannay, H.J., & Levin, H.S. (1985). Selective reminding test: An examination of the equivalence of four forms. Journal of Clinical and Experimental Neuropsychology, 7, 251-263.
18. Heaton, R.K. (1981). Wisconsin Card Sorting Test. Odessa, FL: Psychological Assessment Resources.
19. Heaton, R.K., Kirson, D., Velin, R.A., Grant, I., & HNRC Group (1994). The utility of clinician ratings for detecting cognitive change in HIV infection. In I. Grant & A. Martin (eds.), Neuropsychology of HIV infection (pp. 188-206). New York, NY: Oxford.
20. Heaton, R.K., & Pendleton, M.G. (1981). Use of neuropsychological tests to predict adult patients' everyday functioning. Journal of Consulting Clinical Psychology, 49, 807-821.
21. Hilsabeck, R.C., Perry, W., & Hassanein, T.I. (2002). Neuropsychological impairment in patients with chronic hepatitis C. Journal of Hepatology, 35, 440-446.
22. Hussain, K.B., Fontana, R.J., Moyer, C.A., Su, G.L. Sneed-Pee, N., & Lok, A.S.F. (2001). Comorbid illness is an important determinant of health-related quality of life in patients with chronic Hepatitis C. American Journal of Gastroenterology, 96, 2737-2744.
23. Landis, J.R., & Koch, G.G. (1977). The measurement of observer agreement for categorical data. Biometrics, 33, 159-74.
24. Lee, W.M., Dienstag, J.L., Lindsay, K.L., Lok, A.S., Bondovsky, H.L., & Schiffman, M.L. (2004). Evolution of the HALT-C trial: Pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonresponders-The HALT-C Group. Controlled Clinical Trials, 25, 472-492.
25. McCrea, M., Cordoba, J., Vessey, G., Blei, A.T., & Randolph, C. (1996). Neuropsychological characterization and detection of subclinical hepatic encephalopathy. Archives of Neurology, 53, 758-763.
26. McAndrews, M.P., Farcnik, K., Carlen, P., Damyanovich, A., Mrkonjic, M,. Jones, S., & Heathcote, E.J. (2005). Prevalence and significance of neurocognitive dysfunction in Hepatitis C in the absence of correlated risk factors. Journal of Hepatology, 41, 801-808.
27. McHorney, C.A., Ware, J.E., & Raczek, A.E. (1993). The MOS 36-Item Short-Form Health Survey [SF-36]: II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Medical Care, 31, 247-263.
28. Reitan, R.M., & Wolfson, D. (1993). The Halstead-Reitan neuropsychological test battery: Theory and clinical interpretation. Tucson, AZ: Neuropsychology Press.
29. Ryan E.L., Morgello S., Isaacs K., Naseer M., Gerits P., & the Manhattan HIV Brain Bank (2004). Neuropsychiatric impact of hepatitis C on advanced HIV. Neurology, 62, 957-962.
30. Shiffman, M.L., Di Bisceglie, A.M., Lindsay, K.L., Morishima, C., Wright, E.C., Everson, G.T. et al. (2004). Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who failed prior treatment. Gastroenterology, 126, 1015-1023.
31. Stokx, L., & Gaillard, A.W. (1986). Task and driving performance of patients with a severe concussion of the brain. Journal of Clinical and Experimental Neuropsychology, 8, 421-436.
32. Trahan, D.E., & Larrabee, G.J. (1988). Continuous Visual Memory Test. Odessa, FL: Psychological Assessment Resources.
33. Varma, A.R., & Trimble, M.R. (1997). Subcortical neurologic syndromes. In M.R. Trimble, & J.L. Cummings (eds.), Contemporary behavioral neurology (pp. 223-238). Woburn, MA: Butterworth-Heinemann.
34. Velin, R.A., Heaton, R.K., Grant, I., & the HNRC Group (1994). Everyday functioning and its relationship to cognitive impairment in HIV Disease. In I. Grant & A. Martin (eds.), Neuropsychology of HIV infection. New York, NY: Oxford.
35. Ware, J.E., Gandek, B., & The IQOLA Project Group (1994). The SF-36 Health Survey: Development and use in mental health research and the IQOLA Project. International Journal of Mental Health, 23, 49-73.
36. Ware, J.E., & Sherbourne, C.D. (1992). The MOS 36-item short-form health survey [SF-36]. I. Conceptual framework and item selection. Medical Care, 30, 473-483.
37. Ware, J.E., Snow, K.K., Kosinski, M., & Gandek, B. (1993). SF-36 health survey manual and interpretation guide. Boston, MA: The Health Institute, New England Medical Center.
38. Wechsler, D. (1981). WAIS-R manual. New York, NY: Psychological Corporation.
39. Weissenborn, K., Krause, J., Bokemeyer, M., Hecker, H., Schuler, A., Ennen, J.C., Ahl, B., Manns, M.P., & Boker, K.W. (2004). Hepatitis C virus infection affects the brain-evidence from psychometric studies and magnetic resonance spectroscopy. Journal of Hepatology, 41, 845-851.
40. Woods, S.P., Rippeth, J.D., Frol, A.B., Levy, J.K., Ryan, E., & Soukup, V.M. (2004). Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV. Journal of Clinical and Experimental Neuropsychology, 26, 759-778.
41. Zachary, R.A. (1988). Shipley Institute of Living Scale. Los Angeles, CA: Western Psychological Services.